Crocs, Inc. vs Medpace Holdings Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 2.7× Crocs, Inc.'s market cap. Which is the better fit depends on your goals.
| CROX | MEDP | |
|---|---|---|
Market Cap | $6.31B | $16.90B |
Sector | Consumer Staples | Technology |
52-Week High | $141.19 | $620.59 |
52-Week Low | $73.39 | $393.42 |
Enterprise Value | $7.83B | $16.52B |
Trailing returns across standard periods
Latest headlines on both assets
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →